Dr. Bredesen has released a follow-up study to his 2014 publication, which first introduced a personalized, programmatic approach to combat cognitive decline in individuals displaying varying degrees of memory loss associated with SCI, MCI, and early Alzheimer’s disease.
In his 2016 paper, Dr. Bredesen offers up ten case studies of participants treated with the protocol for a period of time ranging anywhere from five months to two years. The results show unprecedented improvements in hippocampal volume and quantitative neuropsychological testing.
Read the 2016 study in full here: Reversal of cognitive decline in Alzheimer’s disease
For reference: Dr. Bredesen’s 2014 study, Reversal of cognitive decline: A novel therapeutic approach